Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
With
Merck Sharp & Dohme LLC
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Type 2 Diabetes
HbA1c \> = 8.0% and \< = 12.0%
Serum triglyceride concentration \< = 600 mg/dL
Fasting c-peptide \> = 1.0 ng/ml
Body mass index \< = 41 kg/m2
Drug naive patients
You may not be if
History of MI (myocardial infarction), coronary angioplasty or bypass graft(s), valvular disease or repair, unstable angina pectoris, transient ischemic attack (TIA), cerebrovascular accidents, accelerated/malignant hypertension, or hypertension related CHF (congestive heart failure) within six months prior to screening and during the Lead-In Phase.
Women of child Bearing Potential
Uncontrolled hypertension, CHF defined as New York Heart Association (NYHA) Class II, III and IV, exacerbation of previously stable CHF (any NYHA class) or uncontrolled cardiac arrhythmia in the 30 days prior to screening and during the Lead-In Phase.
History of renal disease, bladder cancer, pulmonary disease, gastrointestinal disease, active liver disease or endocrine disease.